Every material Form 8-K KPET Ultra Paceline Corp has filed with the SEC since April 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
KPET Ultra Paceline Corporation, a blank check company, said holders of units from its initial public offering may separately trade its Class A ordinary shares and warrants starting May 21, 2026. Units not separated will continue trading as KPET.U, and the separated shares and warrants will trade as KPET and KPET.WS on the New York Stock Exchange. The filing is administrative and does not report financial results or a business combination.
Separate trading of Class A ordinary shares and warrants begins May 21, 2026
No fractional warrants will be issued on separation; only whole warrants will trade
Trading symbols: KPET.U (units), KPET (shares), KPET.WS (warrants), all on NYSE
Registration statement was declared effective by the SEC on March 30, 2026
KPET Ultra Paceline Corporation said the underwriter exercised its over-allotment option in full and bought 3,000,000 additional units on April 20, 2026, at $10.00 per unit, for $30,000,000 in gross proceeds. A total of $230,000,000 from the IPO, private placement and over-allotment was placed in a trust account, and an unaudited balance sheet as of April 20, 2026 reflecting these proceeds was filed as Exhibit 99.1. The filing covers financing and balance sheet effects only and does not report operating results.
Underwriter bought 3,000,000 over-allotment units on April 20, 2026, at $10.00 per unit, generating $30,000,000 in gross proceeds.
$230,000,000 placed in a trust account with Continental Stock Transfer & Trust Company, including $12,650,000 of deferred underwriting discounts and commissions.
Private placement of 235,000 units at $10.00 per unit to KPET Ultra Paceline Unit Holdings, LLC, generating $2,350,000 in gross proceeds.
Unaudited pro forma balance sheet as of April 20, 2026 filed as Exhibit 99.1; signed by Roger Edward Tamraz, President and Chief Financial Officer.
KPET Ultra Paceline Corporation, a blank check company, completed its initial public offering of 20 million units at $10.00 per unit on April 1, 2026, generating $200 million in gross proceeds. The full $200 million was placed in a trust account, and the company states it has not selected a business combination target, so shareholders' capital is held for a future acquisition that has not yet been identified.
20,000,000 units sold at $10.00 each, for gross proceeds of $200,000,000 on April 1, 2026
Concurrent private placement of 235,000 units at $10.00 each ($2,350,000) to KPET Ultra Paceline Unit Holdings, LLC
$200,000,000 placed in trust with Continental Stock Transfer & Trust Company, including $11,000,000 of deferred underwriting discounts and commissions
Company has not selected a business combination target; it has 24 months from the IPO closing, with one three-month extension at the sponsor's option
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every KPET Ultra Paceline Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →